Capital Research Global Investors’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,244,300	Closed	-$20.7M	–	435
2016 Q4	$20.7M	Sell	1,244,300 -3,179,058	-72%	-$57.5M	0.01%	385
2016 Q3	$91M	Sell	4,423,358 -3,058,777	-41%	-$77.6M	0.03%	280
2016 Q2	$229M	Sell	7,482,135 -1,138,704	-13%	-$39.6M	0.08%	209
2016 Q1	$323M	Sell	8,620,839 -252,193	-3%	-$9.5M	0.11%	173
2015 Q4	$383M	Sell	8,873,032 -67,670	-0.8%	-$2.86M	0.13%	157
2015 Q3	$335M	Hold	8,940,702	–	–	0.12%	169
2015 Q2	$304M	Hold	8,940,702	–	–	0.1%	204
2015 Q1	$317M	Hold	8,940,702	–	–	0.11%	193
2014 Q4	$305M	Buy	8,940,702 +7,268	+0.1%	+$258K	0.1%	199
2014 Q3	$345M	Buy	8,933,434 +215,825	+2%	+$8.05M	0.12%	175
2014 Q2	$339M	Buy	8,717,609 +288,251	+3%	+$10.7M	0.12%	170
2014 Q1	$288M	Buy	8,429,358 +804,473	+11%	+$24.9M	0.1%	186
2013 Q4	$160M	Buy	7,624,885 +1,888,185	+33%	+$47.8M	0.06%	235
2013 Q3	$135M	Buy	5,736,700 +3,035,800	+112%	+$86.2M	0.05%	246
2013 Q2	$72.6M	Buy	+2,700,900	New	+$78.3M	0.03%	289